Previous studies have suggested that leukocyte apheresis, which selectively removes about 65% of activated granulocytes and 55% of activated monocytes from peripheral blood, can improve IBD ...

Lipoprotein apheresis involves the extracorporeal removal of LDL and lipoprotein(a) particles from whole blood or plasma by adsorption, precipitation or differential filtration. Used repetitively ...

The global apheresis machines market size was US$ 3.4 billion in 2021. The global apheresis machines market is forecast to grow to US$ 7.89 billion by 2030 by growing at a compound annual growth rate ...

The global apheresis market was valued at $2.4 billion in 2021 and is projected to reach $5.3 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031.

An apheresis machine is a device which receives blood removed from a patient or donor’s body and separates it into its various components: plasma, platelets, white blood cells and red blood cells.

Apheresis is the process of removing blood from a patient while using a special machine to separate the different components of blood. One or more components are removed to use in treatments or ...

Attendees will learn how subtle differences in the apheresis process can lead to significant discrepancies in the cellular products, ultimately affecting the efficacy of the therapies ...

Apheresis machine for extracorporeal elimination of LDL cholesterol in patients with familial hypercholesterolemia, hyperlipoproteinemia (a), hyperfibrinogenemia, transplant vasculopathy.

The sale to GVS is expected to enhance the company’s focus on its core apheresis solutions, which constitute a significant portion of its blood center business and possess a more promising growth ...

Haemonetics (HAE) announced that it has entered into a definitive agreement to sell its whole blood assets to GVS, a manufacturer of filter ...

Scotlynn SweetPac Growers’ donation of 16,000 pounds of pumpkins for a local event helped raise almost $21,500 for the ...